RADAY GILEAD (Chief Operating Officer) sold 7.5% of their position (14.31M shares) of REDHILL BIOPHARMA LTD. on the open market
Open‑market sale worth $1.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/6/2026ACC: 0001178913-26-004715
Officer· Chief Operating Officer
Since Mar 2026
+13.25M
Net shares
Net buyer
$1.4K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
27.56M acquired · 14.31M disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−14.31M
Price / share
$0.00
Trade value
$1.43K
% of position
7.5%
10/1/2026
191.22M→176.91M
Total
Net shares
−14.31M
Net value
-$1.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 10/1/2026 | S · Sale | −14.31M | $0.00 | $1.43K | 7.5% | 191.22M | 176.91M |
| Total | −14.31M | -$1.43K | ||||||
Derivative Transactions1
American Depository Shares
Direct
Converts to
Ordinary Shares
27.56M shares
Shares
+27.56M
Strike price
Held after
131.69M
Exercisable
—
10/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| American Depository Shares Direct | Ordinary Shares27.56M shares | 10/1/2026 | M · Option Exercise | +27.56M | — | 131.69M |